Dopamine receptor blocker; metabolite of thioridazine and mesoridazine, q.q.v. Prepn: Renz et al., FR 1363683 and FR 1459476 (1964, 1966, both to Sandoz). Pharmacology: Maruyama et al., C.A. 68, 20799z (1968). Effects on dopaminergic function in comparison with mesoridazine and thioridazine: D. M. Niedzwiecki et al., J. Pharmacol. Exp. Ther. 228, 636 (1984); C. D. Kilts et al., ibid. 231, 334 (1984). Clinical evaluation as antipsychotic: R. Axelsson, Curr. Ther. Res. 21, 587 (1977). HPLC determn in plasma: D. A. Ganes, K. K. Midha, J. Chromatogr. 423, 227 (1987).
Antipsychotic.
Antipsychotic; Phenothiazines